Home

James R. Kasinger, General Counsel and Secretary: Crispr Therapeutics CRSP Sell · Filed 03/17

Trade details

Type
Insider sale
Amount
$166,497
Shares · price
3,450 sh · $48.26 a share
Held after
91,240 sh
Trade date
26/03/16
Filed
26/03/17
Days to filing
1 days

Sold 3.6% of holdings

Share of holding sold
3.6%

Crispr Therapeutics trades, last 26 weeks

What else happened in Crispr Therapeutics around then

Filed or reported within 30 days of the trade day · 02/14~04/15

James R. Kasinger's recent trades

  • James R. Kasinger

    Sell10b5-1 planCrispr Therapeutics

    $626.5K

    Filed 09/24

  • James R. Kasinger

    Planned sale10b5-1 planCrispr Therapeutics

    $626.5K

    Filed 09/22

  • James R. Kasinger

    SellCrispr Therapeutics

    $148.9K

    Filed 03/24

  • James R. Kasinger

    SellCrispr Therapeutics

    $147.8K

    Filed 03/12

  • James R. Kasinger

    SellCrispr Therapeutics

    $111K

    Filed 02/20